
Fluidigm Corporation FLDM
Fluidigm Corporation P/E Ratio 2011-2025 | FLDM
Annual P/E Ratio Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -9.08 | -4.05 | -5.76 | -3.56 | -2.3 | -3.61 | -20.3 | -68.7 | -19 | -11.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.3 | -68.7 | -14.8 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-37.1 | $ 19.23 | 1.32 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 20.93 | 1.48 % | $ 225 M | ||
|
Co-Diagnostics
CODX
|
-0.988 | $ 0.17 | -5.48 % | $ 4.99 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 38.94 | -0.94 % | $ 1.08 B | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
39 | $ 229.96 | -0.33 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.39 | -2.88 % | $ 295 M | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.51 | 0.93 % | $ 1.92 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
-10.8 | $ 101.85 | -0.05 % | $ 18.9 B | ||
|
DexCom
DXCM
|
90.1 | $ 66.67 | -0.58 % | $ 25.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 26.21 | -1.06 % | $ 792 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-2.74 | $ 18.94 | -0.68 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-3.57 | $ 99.42 | -0.5 % | $ 3.92 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00564 | $ 3.16 | 1.28 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
26 | $ 226.45 | -0.54 % | $ 41.1 B | ||
|
Guardant Health
GH
|
-13.4 | $ 102.22 | 1.61 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-7.64 | $ 6.13 | -0.65 % | $ 555 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.65 | -2.31 % | $ 2.5 M | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 7.04 | -0.2 % | $ 1.53 B | ||
|
National Research Corporation
NRC
|
32.6 | $ 18.6 | -0.27 % | $ 456 M | ||
|
Illumina
ILMN
|
-13.4 | $ 131.69 | -0.8 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
385 | $ 200.63 | -0.67 % | $ 10.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.19 | -0.73 % | $ 20 B | ||
|
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 174.52 | -0.55 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
-2.14 | $ 6.71 | -0.22 % | $ 870 M | ||
|
Personalis
PSNL
|
-3.12 | $ 8.06 | 1.13 % | $ 478 M | ||
|
Quidel Corporation
QDEL
|
13 | $ 28.91 | -1.33 % | $ 1.22 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
RadNet
RDNT
|
1.32 K | $ 71.39 | -0.14 % | $ 5.21 B | ||
|
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 251.78 | -0.52 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 181.98 | -0.56 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
42.4 | $ 679.68 | -0.39 % | $ 56.1 B | ||
|
Lantheus Holdings
LNTH
|
20.7 | $ 66.52 | -0.95 % | $ 4.6 B | ||
|
Mettler-Toledo International
MTD
|
34.6 | $ 1 398.59 | -1.11 % | $ 29.7 B | ||
|
Agilent Technologies
A
|
34.7 | $ 136.69 | -0.68 % | $ 41.6 B |